MCC

Meningococcal conjugate vaccine · Novartis

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MCC, covering 2014-09-19 to 2019-03-28. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011) [Phase 3]